These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 22387203

  • 1. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
    Rosencher L, Maisonobe T, Lavole A, Milleron B, Ferroir JP.
    Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
    Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V, Chapuis F, Aguera M, Decullier E, Duchemin AM, Graus F, Antoine JC.
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
    [Abstract] [Full Text] [Related]

  • 6. Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2/CRMP-5 antibodies in a patient with small cell lung cancer.
    Dericioglu N, Gocmen R, Tan E.
    Clin Neurol Neurosurg; 2018 Jul; 170():117-119. PubMed ID: 29777943
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Paraneoplastic neurological syndrome as an initial indicator of small cell carcinoma of the lung.
    Porto L, Miranda M, Gomes A, André R, Rodrigues B.
    BMJ Case Rep; 2013 Feb 06; 2013():. PubMed ID: 23391962
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comments on the review by R. Kaiser. Paraneoplastic neurological syndromes, diagnostic and pathogenetic significance of autoantibodies].
    Pfadenhauer K.
    Nervenarzt; 2000 Feb 06; 71(2):143-4. PubMed ID: 10703018
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
    Zekeridou A, Majed M, Heliopoulos I, Lennon VA.
    Thorac Cancer; 2019 Apr 06; 10(4):1001-1004. PubMed ID: 30810271
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor.
    de la Sayette V, Bertran F, Honnorat J, Schaeffer S, Iglesias S, Defer G.
    Arch Neurol; 1998 Mar 06; 55(3):405-8. PubMed ID: 9520015
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.